Delivery Order SPE2DB22D1106-SPE2DB25FEZA3
- Not listed
- The Defense Logistics Agency awarded a $5,168.16 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX under a firm fixed price contract, with an ultimate completion date of August 13, 2025. This is a non-set-aside, competitively awarded delivery order issued on July 23, 2025, with performance to be completed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency awarded a $30,112.50 delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of 200-unit vials of BOTOX under a firm fixed-price contract. The order is due for completion by July 31, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements through open...
- The Defense Logistics Agency awarded a delivery order valued at $1,722.72 to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX on July 10, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order valued at $21,534.00 to AmerisourceBergen Drug Corp for the supply of BOTOX 100 unit vials, with an ultimate completion date of July 2, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a direct order fulfillment under the vendor's broader pharmaceutical supply agreement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,419.20 for 200-unit vials of BOTOX on July 21, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999...
- The Defense Logistics Agency awarded a $20,514.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX, with a completion date of July 22, 2025. This competitive award, with no set-aside designation, is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a $10,257.48 delivery order to AmerisourceBergen Drug Corp for BOTOX 200 Unit Vials on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with...
- The Defense Logistics Agency awarded a delivery order valued at $4,273.95 to AmerisourceBergen Drug Corp for the supply of BOTOX 200 Unit Vials. This firm fixed-price, competitively awarded delivery order has an ultimate completion date of August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,574.80 on September 15, 2025, for the supply of BOTOX Cosmetic 100 Unit Vials, with an ultimate completion date of October 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania,...
- The Defense Logistics Agency awarded a $85,479.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BOTOX 200 Unit Vials, with an ultimate completion date of August 12, 2025. This is a non-set-aside competitive award issued as a child contract, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as part...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZA3Delivery Order
The Defense Logistics Agency awarded a $21,534 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX, with a completion date of August 12, 2025. This non-set-aside competitive award was issued on July 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves the Defense Health Agency and other military healthcare systems through its extensive pharmaceutical supply network. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to military healthcare programs worldwide, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. The company's federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements through open competition, supporting the Defense Logistics Agency's mission to provision pharmaceutical products for military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.5k | 7/22/25 |